MarketReportsOnline.com adds "Asia Breast Cancer Screening Market Forecast (Mammography, MRI & Ultrasound)" report to its research store.

Pune, India -- (SBWire) -- 07/19/2017 --This 111 page report with 101 Figures and 8 Tables provides a complete analysis of top 7 countries of Asia breast cancer screening market. All the 7 countries in the report have been studied from 7 viewpoints.

7 Asian Countries Coverage: India, China, Japan, Korea, Singapore, Thailand & Malaysia

Complete report available at http://www.marketreportsonline.com/630809.html.

Asia breast cancer screening market size is expected to cross over US$ 4 Billion by 2022. China, Japan and Korea are the top most contributors. Increasing breast cancer awareness, government and NGOs support breast cancer screening programs and ageing women population are major driving forces for this market. Key threats for breast cancer market in Asia are societal fear, misconceptions and cultural barriers for Breast Cancer Screening. Other major challenge being faced by almost all Asian countries is non availability of national level screening program; however partial or regional screening programs are available in few of these countries.

China is Clear Winner in Asia Breast Cancer Screening Market

China is clear winner in the Asia breast cancer screening market. It controls nearly three fourth of the total screening market due to its large women population. Despite poor awareness about breast cancer screening, government partial screening programs and Global as well as domestic NGOs initiatives is helping China to become leader in the Asian breast cancer screening market.

Purchase a copy of this "Breast Cancer Screening Market" research report at http://www.marketreportsonline.com/contacts/purchase.php?name=630809.

Mammogram is leading Methods for Breast Cancer Screening in Asia

Mammogram is leading methods for the breast cancer screening in the Asian countries. Other popular available methods are MRI and Ultrasound. China, Japan and Korea are top three countries for breast cancer mammogram screening. Their combined share was over 90 percent in 2016. India, Singapore, Malaysia and Thailand are other market for breast cancer mammogram screening.

This latest research report "Asia Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast" analyzes the Asia market For Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market. This report studies separate comprehensive analytics for the 7 Asian countries: India, China, Japan, Korea, Singapore, Thailand and Malaysia.

Asia Breast Cancer Screening Market and Forecast:

Asian Countries Breast Cancer Mammography Screening Population Numbers and Forecast

Asian Countries Breast Cancer MRI & Ultrasound Screening Population Numbers and Forecast

Asian Countries Breast Cancer Mammography Screening Market and Forecast

Asian Countries Breast Cancer MRI Screening Market and Forecast

Asian Countries Breast Cancer Ultrasound Screening Market and Forecast

Asian Countries Breast Cancer Screening Market and Forecast

Key Topics covered:

1. Executive Summary
2. Asia Screening Population Analysis
3. Asia Breast Cancer Screening Market Analysis
4. Asia Breast Cancer Screening Population & Market Share Analysis
5. Asia Breast Cancer Screening Market Share Analysis
6. Japan
7. Korea
8. Singapore
9. Malaysia
10. India
11. China
12. Thailand
13. Breast Cancer Screening Market Growth Drivers
14. Breast Cancer Screening Market Challenges

Other Related Reports on Breast Cancer Screening Market:

Global Breast Cancer Market: Industry Analysis & Outlook (2017-2021): 'Breast cancer' defines a malignant tumor that has developed from cells in the breast. Some breast cancers are called in situ as they are confined within the ducts (ductal carcinoma in situ or DCIS) or lobules (lobular carcinoma in situ or LCIS) where they originated. Although, less commonly, breast cancer can also instigate in the stromal tissues, which include the fatty and fibrous connective tissues of the breast. Order a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=567744.

Europe Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast to 2022: Europe Breast Cancer Screening Market will be less than US$ 8 Billion by the end of year 2022. Breast cancer is one of the most dangerous diseases in the Europe region. Its incidence rate in Europe was 92.9 women per 100,000 women and mortality rate was 23.1 per 100,000 women. So, most of the countries of Europe has adopted or in the process to adopt breast cancer screening in their national cancer screening programs. Mammography screening is most commonly used as breast cancer screening method in Europe. Order a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=599726.

About MarketReportsOnline
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com